Tuesday, June 2, 2026
NewsezeNews with Rewards · Earn while you read
+5 credits / query
medicine

Waist-to-Hip Ratio May Offer Better Indicator of Obesity, Health Over BMI

Newseze Wire·Mon, Jun 1, 10:13 PMWire: Healthline
Open original source Read full story (in-site)
Waist-to-Hip Ratio May Offer Better Indicator of Obesity, Health Over BMI

BMI measurements may drastically underestimate obesity rates among U.S. adults, new research suggests.

Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Healthline; tap "Open original source" above to read their full reporting and support the contributing newsroom directly.

Newseze Analysis76 words · original commentary · full read loading…
BMI measurements may drastically underestimate obesity rates among U.S. adults, new research suggests. The story falls into Newseze's medicine desk and is being actively tracked by our editorial team. Calm framing, primary-source references, and respectful tone — every Newseze story is scored for drama and conspiracy before it reaches you. Worth knowing: Newseze refreshes its newsroom every 15 minutes and flags fast-moving local and breaking news as it develops. Watch this page for updates. Reporting: Healthline.
Reader CommentsBe the first reader · Subscribe to join

No comments yet. Be the first.

Related stories

Only 20% of Sunscreens Meet Safety Standards. What to Know Before You Buy
MEDICINETrending Rightcentertrust 78
Only 20% of Sunscreens Meet Safety Standards. What to Know Before You Buy

Why it mattersThe EWG reports that only 20% of sunscreens meet safety standards. Image Credit: Ani Dimi/Stocksy Only about 20% of sunscreens meet leading safety and efficacy standards, according to a recent report from the Environment…

The EWG reports that only 20% of sunscreens meet safety standards. Image Credit: Ani Dimi/Stocksy Only about 20% of sunscreens meet leading safety and efficacy …

ChellaBy Chella·1d ago
WireHealthline
Lilly's Retatrutide Achieves Biggest Weight Loss in Trial History, Outpacing Current GLP-1 Drugs and Surgery
MEDICINEcentertrust 89
Lilly's Retatrutide Achieves Biggest Weight Loss in Trial History, Outpacing Current GLP-1 Drugs and Surgery

Why it mattersA new triple-hormone drug shows clinical results that could reshape obesity treatment and reduce demand for invasive bariatric surgery, potentially lowering costs and expanding access to effective weight management.

A new experimental weight loss drug from Eli Lilly shows dramatic results that rival current GLP-1 drugs and bariatric surgery. Image Credit: Scott Olson/Getty …

ChellaBy Chella·1d ago
WireHealthline